*By Carlo Versano*
As Canadians celebrated Wednesday's cannabis legalization, one California-based dispensary completed the largest acquisition in the industry to date in America, becoming the most valuable U.S. pot company in the process.
MedMen's purchase of medical marijuana vendor PharmaCann for $682 million in stock marks a turning point in the push toward federal legalization, said the company's SVP of corporate communication, Daniel Yi.
Speaking to Cheddar from the floor of MedMen's original retail outpost in West Hollywood, Calif., on an "historic day" for cannabis users, Yi said the deal would not have been possible when the company opened its first store in 2015.
Changing consumers' attitudes toward the drug ー reflected first by investors and then some politicians ー has allowed MedMen to scale its operation, which now includes 14 retail locations in four states. Yi said the plan is to expand to 66 locations in two years.
Yi also said he hopes the legalization efforts in Canada will exert pressure on the "crazy federal laws" for marijuana in the U.S., where it's still classified as a Schedule I narcotic by the DEA ー a category that also includes heroin and cocaine.
Canada's entire legal weed market is estimated to be worth around $6.5 billion ー far less than the established $11 billion market in just the state of California. The potential national cannabis market in the U.S. is $75 billion, Yi said.
"From an economic standpoint, I don't think Canada is going to be a huge game changer."
But what it does politically will be priceless, he said, by "expanding a global conversation" over the potential for cannabis ー whether it's as an opioid replacement or just as a cure for a stressful week.
For full interview [click here](https://cheddar.com/videos/medmen-watches-canadas-cannabis-legalization-roll-out).
Adtalem CEO Steve Beard addresses a report from Safkhet Capital taking the short position on the for-profit education giant, plus why he believes there should be financial recourse for student loan borrowers misled by their institutions.
CEO of Americares Christine Squires shares how the organization is helping provide medical assistance in a time of increasing instability, war, and climate-related disaster.
Doug Clinton, Deepwater Asset Management managing partner, shares tips for investors looking to take advantage of the massive boom in artificial intelligence beyond Microsoft and Nvidia.
Jason Moser, analyst and adviser at the Motley Fool, shares thoughts on recent tech earnings, including what’s behind Google’s share price drop and why A.I. could be Microsoft’s ‘iPhone moment.’
CEOs of social media platforms like Facebook, TikTok, and more meet with lawmakers Wednesday about how they are protecting children from sexual exploitation.
San Francisco 49ers president Al Guido discusses what goes into preparing for Super Bowl LVIII, building a championship-ready team, and how Taylor Swift and streaming are both bringing new fans to the NFL.
A $1 billion loss from a six-week strike did not crash GM's net income last year, which instead rose 12% — and the automaker expects improvement in 2024, too.
Accrue CEO and founder Michael Hershfield explains why Americans' credit card delinquencies are on the rise, advice on what can help, and the key difference between Boomers and Gen Z when it comes to money.
Senior Economist at Morning Consult Kayla Bruun shares thoughts on what to expect from the Fed's January meeting and where monetary policy is headed, as well as how consumers are faring.
